NASDAQ · SHPH
Shuttle Pharmaceuticals Holdings, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for SHPH: Nov 12, 2026
Shuttle Pharmaceuticals Holdings, Inc. Common Stock is estimated to report earnings on 11/12/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-10.5.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Fintel · RTTNews · Quiver Quantitative- Fintel · Oct 22, 9:08 PM EDTShuttle Pharmaceuticals Holdings, Inc. Dismisses Forvis Mazars, LLPOn October 16, 2026, the Audit Committee of the Board of Directors of Shuttle Pharmaceuticals Holdings, Inc., and the full Board, approved the dismissal of Forvis Mazars, LLP as the Company’s independent registered public accounting firm. The dismissal is effective followin
- RTTNews · May 1, 6:12 AM EDTShuttle Pharma Acquires United Dogecoin; Initiates $11 Mln PIPE(RTTNews) – Shuttle Pharmaceutical Holdings Inc. (SHPH), a clinical-stage pharmaceutical company, announced on Thursday a merger agreement to acquire United Dogecoin, a cryptocurrency mining company of Dogecoin.
- RTTNews · Jan 20, 9:29 AM ESTShuttle Pharma Rockets Over 100% As AI Drug Discovery Gains Attention(RTTNews) – Shuttle Pharmaceuticals Holdings, Inc. (SHPH) shares surged by 158% in pre-market trading to $4.21, following investor interest in its oncology pipeline and recent developments highlighting the role of artificial intelligence in drug discovery.
- RTTNews · Nov 29, 6:35 AM ESTShuttle Pharma Appoints Christopher Cooper As Interim CFO(RTTNews) – In the SEC filing, Shuttle Pharmaceuticals Holdings, Inc. (SHPH) announced on Friday that Timothy Lorber has resigned as Chief Financial Officer on November 21, 2025.
- RTTNews · Oct 10, 11:19 AM EDTShuttle Pharmaceuticals Signs LOI To Acquire AI Drug Discovery Firm Molecule.ai(RTTNews) – Friday, Shuttle Pharmaceuticals Holdings, Inc. (SHPH) said it has signed a non-binding letter of intent to buy Molecule.ai, a company focused on using artificial intelligence for drug discovery.
- Quiver Quantitative · Jun 24, 4:21 PM EDTShuttle Pharmaceuticals Holdings, Inc. Closes $4.25 Million Private Placement to Support Growth InitiativesShuttle Pharmaceuticals raises $4.25 million through private placement, aiming to enhance cancer treatment outcomes.
- Quiver Quantitative · Jun 12, 8:42 AM EDTShuttle Pharmaceuticals Holdings, Inc. Proposes 25-for-1 Reverse Stock Split to Comply with Nasdaq RequirementsShuttle Pharmaceuticals proposes a 25-for-1 reverse stock split, pending Nasdaq approval, to strengthen its capital structure.
- Quiver Quantitative · May 15, 4:50 PM EDTShuttle Pharmaceuticals Provides Corporate Update on Phase 2 Clinical Trial of Ropidoxuridine for Glioblastoma and Advances Diagnostics InitiativeShuttle Pharmaceuticals announced progress in glioblastoma trial and advancements in diagnostics and board expansion.
- Quiver Quantitative · Apr 21, 4:23 PM EDTShuttle Pharmaceuticals to Present Phase 2 Trial Update at Planet MicroCap Showcase: VEGAS 2025Shuttle Pharmaceuticals to present Phase 2 trial updates and diagnostic advancements at Planet MicroCap Showcase in Las Vegas.
- Quiver Quantitative · Mar 13, 4:22 PM EDTShuttle Pharmaceuticals Holdings, Inc. Closes $5.75 Million Public Offering to Fund Phase II Clinical TrialShuttle Pharmaceuticals raised approximately $5.75 million through a public offering to fund its Phase II clinical trial and operations.
- Quiver Quantitative · Mar 12, 6:30 AM EDTShuttle Pharmaceuticals Appoints Christopher Cooper as Interim Co-CEO to Enhance Business Strategy and Capital Markets FocusShuttle Pharmaceuticals appoints Christopher Cooper as interim Co-CEO to enhance business operations while Dr. Anatoly Dritschilo focuses on scientific efforts.
- Quiver Quantitative · Feb 26, 10:57 AM ESTShuttle Pharmaceuticals Holdings, Inc. Reports Progress on Phase 2 Trial and Diagnostic Advancements in Annual UpdateShuttle Pharmaceuticals updates on clinical trial progress and diagnostics advancements, showing commitment to improving cancer treatment outcomes.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Shuttle Pharmaceuticals Holdings, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.